| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
2025 |
| issn |
1538-8514
1535-7163 |
| issueIdentifier |
11 |
| pageRange |
2025-2025 |
| publicationName |
Molecular Cancer Therapeutics |
| startingPage |
2025 |
| bibliographicCitation |
Gilmer TM. Lapatinib: functional genomics study leads to insights into mechanism of action. Mol Cancer Ther. 2011 Nov;10(11):2025. doi: 10.1158/1535-7163.mct-11-0700. PMID: 22072809. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fab090b0b5d44da408ca4b1d86276586 |
| date |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1158/1535-7163.mct-11-0700
https://pubmed.ncbi.nlm.nih.gov/22072809 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1535-7163
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
https://portal.issn.org/resource/ISSN/1538-8514 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Lapatinib: Functional Genomics Study Leads to Insights into Mechanism of Action |
| discusses |
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0001483 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011799Q000494
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D015972 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801 |